Manuel Jesús Muñoz (Manuel J Muñoz)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Genome Wide Association

Cognitive Decline

Top Venues

G3 (Bethesda, Md.)

Briefings in functional genomics

Foods (Basel, Switzerland)

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Ana M Brokate-Llanos, Mireya Sanchez-Ibañez, Mercedes M Pérez-Jiménez, José M Monje-Moreno, Carlos Gómez-Marín, Carlos Caro, Carlos Vivar-Rios, Miguel A Moreno-Mateos, María L García-Martín, Manuel Jesús Muñoz, José L Royo
Ribonucleotide reductase inhibition improves the symptoms of a Caenorhabditis elegans model of Alzheimer's disease. G3 (Bethesda, Md.) 14 (5) (2024)
Cristina Moral-Turón, Gualberto Asencio-Cortés, Francesc Rodriguez-Diaz, Alejandro Rubio, Alberto G Navarro, Ana M Brokate-Llanos, Andrés Garzón, Manuel Jesús Muñoz, Antonio J Pérez-Pulido
ASACO: Automatic and Serial Analysis of CO-expression to discover gene modifiers with potential use in drug repurposing. Briefings in functional genomics 23 (4) (2024)
Ana M Brokate-Llanos, Mireya Sanchez-Ibañez, Mercedes M Pérez-Jiménez, José M Monje-Moreno, Carlos Gómez-Marín, Carlos Caro, Carlos Vivar-Rios, Miguel A Moreno-Mateos, María L García-Martín, Manuel Jesús Muñoz, José L Royo
Ribonucleotide reductase inhibition improves the symptoms of a Caenorhabditis elegans model of Alzheimer's disease. G3 (Bethesda, Md.) 14 (5) (2024)
Ana M Brokate-Llanos, Mireya Sanchez-Ibañez, Mercedes M Pérez-Jiménez, José M Monje-Moreno, Carlos Gómez-Marín, Carlos Caro, Carlos Vivar-Rios, Miguel A Moreno-Mateos, María L García-Martín, Manuel Jesús Muñoz, José L Royo
Ribonucleotide reductase inhibition improves the symptoms of a Caenorhabditis elegans model of Alzheimer's disease. G3 (Bethesda, Md.) 14 (5) (2024)
Ana M Brokate-Llanos, Mireya Sanchez-Ibañez, Mercedes M Pérez-Jiménez, José M Monje-Moreno, Carlos Gómez-Marín, Carlos Caro, Carlos Vivar-Rios, Miguel A Moreno-Mateo, María L García-Martín, Manuel Jesús Muñoz, José L Royo
Ribonucleotide reductase inhibition improves the symptoms of a Caenorhabditis elegans model of Alzheimer's Disease. G3 (Bethesda, Md.) (2024)
Cristina Moral-Turón, Gualberto Asencio-Cortés, Francesc Rodriguez-Diaz, Alejandro Rubio, Alberto G Navarro, Ana M Brokate-Llanos, Andrés Garzón, Manuel Jesús Muñoz, Antonio J Pérez-Pulido
ASACO: Automatic and Serial Analysis of CO-expression to discover gene modifiers with potential use in drug repurposing. Briefings in functional genomics (2024)
Ana M Brokate-Llanos, Mireya Sanchez-Ibañez, Mercedes M Pérez-Jiménez, José M Monje-Moreno, Carlos Gómez-Marín, Carlos Caro, Carlos Vivar-Rios, Miguel A Moreno-Mateos, María L García-Martín, Manuel Jesús Muñoz, José L Royo
Ribonucleotide reductase inhibition improves the symptoms of a Caenorhabditis elegans model of Alzheimer's disease. G3 (Bethesda, Md.) 14 (5) (2024)
Cristina Moral-Turón, Gualberto Asencio-Cortés, Francesc Rodriguez-Diaz, Alejandro Rubio, Alberto G Navarro, Ana M Brokate-Llanos, Andrés Garzón, Manuel Jesús Muñoz, Antonio J Pérez-Pulido
ASACO: Automatic and Serial Analysis of CO-expression to discover gene modifiers with potential use in drug repurposing. Briefings in functional genomics 23 (4) (2024)
Ana M Brokate-Llanos, Mireya Sanchez-Ibañez, Mercedes M Pérez-Jiménez, José M Monje-Moreno, Carlos Gómez-Marín, Carlos Caro, Carlos Vivar-Rios, Miguel A Moreno-Mateos, María L García-Martín, Manuel Jesús Muñoz, José L Royo
Ribonucleotide reductase inhibition improves the symptoms of a Caenorhabditis elegans model of Alzheimer's disease. G3 (Bethesda, Md.) 14 (5) (2024)
Alvaro Esteban-Martos, Ana Maria Brokate-Llanos, Luis Miguel Real, Sonia Melgar-Locatelli, Itziar De Rojas, Adriana Castro-Zavala, Maria Jose Bravo, Maria Del Carmen Mañas-Padilla, Pablo García-González, Maximiliano Ruiz-Galdon, Beatriz Pacheco-Sánchez, Rocío Polvillo, Fernando Rodríguez de Fonseca, Irene González, Estela Castilla-Ortega, Manuel Jesús Muñoz, Patricia Rivera, Armando Reyes-Engel, Agustin Ruiz, Jose Luis Royo
A Functional Pipeline of Genome-Wide Association Data Leads to Midostaurin as a Repurposed Drug for Alzheimer's Disease. International journal of molecular sciences 24 (15) (2023)
Amel Hamdi, Isabel Viera-Alcaide, Rafael Guillén-Bejarano, Rocío Rodríguez-Arcos, Manuel Jesús Muñoz, Jose Manuel Monje Moreno, Ana Jiménez-Araujo
Asparagus Fructans as Emerging Prebiotics. Foods (Basel, Switzerland) 12 (1) (2022)
Amel Hamdi, Isabel Viera-Alcaide, Rafael Guillén-Bejarano, Rocío Rodríguez-Arcos, Manuel Jesús Muñoz, Jose Manuel Monje Moreno, Ana Jiménez-Araujo
Asparagus Fructans as Emerging Prebiotics. Foods (Basel, Switzerland) 12 (1) (2022)
Amel Hamdi, Isabel Viera-Alcaide, Rafael Guillén-Bejarano, Rocío Rodríguez-Arcos, Manuel Jesús Muñoz, Jose Manuel Monje Moreno, Ana Jiménez-Araujo
Asparagus Fructans as Emerging Prebiotics. Foods (Basel, Switzerland) 12 (1) (2022)
Mercedes Maria Pérez-Jiménez, Jose Manuel Monje Moreno, Ana María Brokate-Llanos, Mónica Venegas-Calerón, Alicia Sánchez-García, Paula Sansigre, Amador Valladares, Sara Esteban-García, Irene Suárez-Pereira, Javier Vitorica, José Julián Ríos, Marta Artal-Sanz, Ángel M Carrión, Manuel Jesús Muñoz
Steroid hormones sulfatase inactivation extends lifespan and ameliorates age-related diseases. Nature communications 12 (1) (2021)
Antonio J Pérez-Pulido, Gualberto Asencio-Cortés, Ana M Brokate-Llanos, Gloria Brea Calvo, Rosario Rodríguez-Griñolo, Andrés Garzón, Manuel Jesús Muñoz
Serial co-expression analysis of host factors from SARS-CoV viruses highly converges with former high-throughput screenings and proposes key regulators and co-option of cellular pathways. bioRxiv : the preprint server for biology (2020)